A comparative study of histone acetylation in neuronal and glial nuclei enriched rat brain fractions  by Sarkander, H.-I. et al.
Volume 52, number 1 FEBS LETTERS March 1975 
A COMPARATIVE STUDY OF HISTONE ACETYLATION IN NEURONAL AND GLIAL 
NUCLEI ENRICHED RAT BRAIN FRACTIONS 
H.-I. SARKANDER, H. FLEISCHER-LAMBROPOULOS and W. P. BRADE 
Pharmakologisches Institu t der Freien Universitiit Berlin, D-I 000 Berlin 33, Thielallee 69- 73, West Germany 
Received 25 January 1975 
1. introduction 
Neuronal chromatin ternplated transcription is much 
less restricted than that of oligodendro- and microglia 
[ 1,2] . These differences in chromatin template 
restriction are connected with differences in chromatin 
composition [3,4] and structure [S,lO] and may be 
related to different enzymatic modifications of 
chromosomal proteins such as the previously described 
higher phosphorylation of neuronal nonhistone 
proteins [4]. 
Since the basic chromosomal proteins are certainly 
involved in determining chromatin structure [6] and 
in restricting the template capacity of DNA for in 
vitro synthesis [7,8] we were interested in the question 
whether and in what way nuclear histone transacetylases 
and deacetylases contribute to the structural and 
functional differences between neuronal and glial 
chromatin. 
In the present paper we report on the higher 
acetylation of ‘neuronal’ chromatin-bound histones 
than ‘glial’ histones, on the very low deacetylation of 
histones by both the ‘neuronal’ and ‘glial’ nuclei and 
on the effect of in vitro histone acetylation on 
endogenous RNA polymerase activities in ‘neuronal’ 
and ‘glial’ nuclear fractions. 
2. Methods 
2.1. Isolation of cell nuclei 
Rat brain nuclei were isolated from female Wistar 
rats (150-l 70 g body weight) as described elsewhere 
[9]. Neuronal (N) and glial (G) enriched nuclear 
fractions were separated from isolated rat brain nuclei 
40 
by discontinuous sucrose density gradient centrifugation 
[4,9]. The nuclear fractions obtained corresponded 
morphologically to those described previously [4,9] 
and characterized by [5,10,11]. 
2.2. Histone acetylation and deacetylation 
Histones were acetylated up to maximum values by 
incubating neuronal or glial nuclei enriched fractions 
(250 fig DNA) with 9.8 &i [3H] acetylcoenzyme A 
(spec. act. 187 mCi/mmol) in 0.32 M sucrose containing 
3 mM MgClz and 20 mM Tris-HCl pH 7.4 for 40 min 
at 37°C. Thereafter aliquots of the incubation assay 
were pipetted into ice-cold Hz SO4 up to a final 
concentration of 0.4 N. Histones were extracted from 
the aliquots as described previously [12,19]. For 
determination of acetate retention in histones an excess 
of unlabeled acetylcoenzyme A was added at 40 min of 
incubation and the reaction was further incubated for 
60 min and stopped by adding ice-cold Hz SO4 up to 
0.4 N. 
2.3, Gel electrophoresis and radioanalysis of histones 
Equal amounts of histones dissolved in 0.9 N acetic 
cid were separated by polyacrylamide gel electro- 
phoresis in the presence of 3.125 M urea at 1 mA per 
13.5 X 0.5 cm tube for 7 hr according to Panyim and 
Chalkley [ 131. Gels were stained with 0.1% amido- 
black 10 B in 7% acetic acid containing 20% ethanol 
destained in 7% acetic acid with 35% ethanol and 
scanned at 600 nm using a Gilford spectralphotometer 
model 240 with scanning attachment. After cutting 
the gels into 1 mm slices using the apparatus described 
elsewhere [ 141 gel slices were depolymerized by 
30% Hz O2 and dissolved in Bray’s scintillation solution 
[ 151 containing 1% NCS (Nuclear Chicago Solubilizer, 
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Table 1 
Effect of preincubation of neuronal and glial enriched nuclear fractions with acetylcoenzyme A on 
endogenous RNA polymerase activities. 
Nuclear fraction [ 3 H] UMP incorporated (dpm X ~.cg DNA-‘) 
No preincubation (*) 
preincubation 
with (+) and without (--) 
acetylcoenzyme A 
‘Neuronal’ (*) 
(-) 
(+) 
‘Glial (*) 
(-) 
(+) 
Low ionic 
strength conditions 
63.7 f 2.1 
59.2 f. 1.6 
81.5 f 1.3 
26.5 f 1.2 
24.3 + 1.9 
30.3 r 1.7 
High ionic 
strength conditions 
306.3 f 15.8 
281.8 f 11.3 
379.8 + 13.9 
158.7 * 4.9 
147.1 + 3.1 
192.1 f 6.3 
After incubating the ‘neuronal’ and ‘glial’ nuclear suspension (about 500 I.cg DNA) with 500 pmol 
acetylcoenzyme A under conditions as described in Methods for 3 min 0.2 ml (about 50 rg DNA) of 
the suspensions were transferred to the RNA polymerase assays which contained 16.6 r&i [ ‘H] UTP 
(spec. act. 80 mCi/mmol) and UMP incorporation into an acid precipitable product was determined 
as described elsewhere [ 12,191. Each value represents the arithmetic mean f S.E.M. from 3 experiments. 
Amersham/Searle, Illinois, USA). Radioactivity was 
determined in a Packard Liquid Scintillation Counter 
model 3380 using external standardisation. The 
efficiency for 3H was 26.4%. Incorporation of radio- 
activity into total histones was determined as described 
by Sekeris [ 161. DNA and protein were determined 
by the method of Burton [ 171 and Lowry [ 181 
respectively. 
3. Results and discussion 
The endogeneous nuclear RNA polymerase activities 
at high and low ionic strength conditions are 93 and 
140% higher in our ‘neuronal’ than in the ‘glial’ fraction 
(table 1) which is in agreement with reports in 
literature [ 1,2] . The higher in vitro RNA synthesis in 
the neuronal type nuclei corresponds with a higher 
nuclear acetylation rate of ‘neuronal’ histones (fig. 1) 
if compared to ‘glial’ histones. In the presence of an 
excess of acetylcoenzyme A the uptake capacity for 
[3H] acetate in the ‘neuronal’ chromatin-bound histones 
is nearly twice as much as in the ‘glial’ histones. This 
is connected with a’more rapid uptake of [3H] acetate 
by ‘neuronal’ than by ‘glial’ histones during the first 
20 min of incubation (fig.1 B) when acetylation 
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Fig.1. [ sH] acetyl incorporation into total histones by neuronal 
(v---V) and glial (e---e) nuclei enriched rat brain fractions. 
(A) Dependence on increasing amounts of [3H]acetylcoenzyme 
A (spec. act. 187 mCi/mmol). (B) Dependence on incubation 
time. 
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Fig.2. Acetylation and deacetylation of histone fractions from neuronal (N) and glial (G) enriched nuclei of rat brain. Upper part: 
Densitometric tracings and photographs of the banding profiles of ‘neuronal’ and ‘glial’ acetylated histones. Lower part: 50 pg 
histones acetylated up to maximal values by incubating the nuclear fractions with [ sH] acetylcoenzyme A for 40 min (o--o) and 
after further incubation for 60 min in the presence of an excess of unlabeled acetylcoenzyme A (o---o) were gelelectrophoretically 
separated, scanned, sliced and radioanalyzed as described in Methods. 
occurs linearily with time. The [3H] acetate taken up including a reiterated use of [3H] acetate or from a 
after 40 mm of incubation is associated mainly with relatively slow deacetylation or from both these 
F3, F2b, F2a fractions of ‘neuronal’ as well as of ‘glial’ processes. In order to differentiate between the three 
histones (fig.2). possibilities the histone-bound [‘HI acetate was chased 
The plateau values of acetate incorporation into in the presence of an excess of unlabeled acetylcoenzyme 
‘neuronal’ and ‘glial’ histones after 40 min of incubation A for 60 min after histones had been saturated with 
could result either from a relatively fast acetylation [‘HI acetate (fig.2). 
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Interestingly none of the histone fractions did 
release its incorporated acetate during the 60 min chase 
period. This is different to rat liver where histone 
deacetylation occurred under the same experimental 
conditions [ 191. At present it is difficult to give a 
sufficient explanation for the low deacetylation of 
chromatin-bound histones in the rat brain nuclear 
fractions. However, an artificial reduction of deacetylase 
activity due to the isolation procedure for ‘neuronal 
and ‘glial’ nuclei is not very likely since transacetylases, 
RNA polymerases [20], protein kinases [4] and enzymes 
responsible for nuclear amino acid incorporation [9] 
are highly active in these nuclear populations. Since no 
measurable deacetylase activity was found neither in 
‘neuronal) nor in ‘glial’ nuclei as early as after 3 min of 
incubation a loss of deacetylase activity due to the 
length of the chasing period can be excluded. 
The biological meaning of ‘neuronal’ and ‘glial 
histone acetylation for in vitro RNA synthesis is 
reflected in table 1. Prelncubation of neuronal enriched 
nuclei with acetylcoenzyme A for 3 min is connected 
with an acetate uptake into chromatin-bound histones 
of 0.275 pmol acetate/pg DNA X min and leads to an 
increase of UMP incorporation of 0.185 pmol UMP/pg 
DNA X min under high ionic strength conditions and 
in the presence of Mn2+ ions and to an increased 
incorporation of 0.041 pmol UMP/pg DNA X min 
under low ionic strength conditions and in the presence 
of Mg2’ ions. Under identical conditions uptake of 
0.099 pmol acetate/pg DNA X min into ‘glial’ histones 
corresponds to an increase of incorporation of 
0.085 pmol UMP/pg DNA X min by high ionic 
strength and Mn”-dependent nuclear RNA polymerase 
and to an increase of UMP incorporation of 0.011 pmol/ 
pg DNA X min catalyzed by low ionic strength and 
Mg2’-dependent RNA polymerase. (LIMP values 
calculated from table 1). So a positive correlation 
seems to exist between the extent of acetylation of 
chromatin-bound histones and the extent of chromatin 
ternplated UMP incorporation by endogenous RNA 
polymerases in ‘neuronal’ nuclei compared to that in 
‘glial’ nuclei. The data of table 1 and fig.1 further 
suggest hat acetylation of a few acetate binding sites 
in chromatin-bound ‘neuronal’ and ‘glial’ histones 
leads to an increased transcription of chromatin-DNA 
whereas the higher saturation values of acetate 
binding to chromatin-bound ‘neuronal’ histones as 
compared to ‘glial’ ones (fig.1) may be connected 
with more acetyl binding sites and to the looser 
structures of the ‘neuronal’ chromatin. 
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